Impact of fenestration creation on managing patients with protein loosing enteropathy complicating Fontan procedure

Protein loosing enteropathy (PLE) is well known complication following Fontan procedure and one way of managing such complication is to create fenestration if it is not present or enlarging it if it is small to reduce the Fontan pressure and reduce venous congestion which end up by intestinal protei...

Full description

Bibliographic Details
Main Authors: Mashail Alobaidan, Jasim Abdulhameed
Format: Article
Language:English
Published: SpringerOpen 2014-03-01
Series:The Egyptian Heart Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1110260813001555
id doaj-8e42989ae4914a409ce9163d1f6b3be4
record_format Article
spelling doaj-8e42989ae4914a409ce9163d1f6b3be42020-11-25T02:19:09ZengSpringerOpenThe Egyptian Heart Journal1110-26082014-03-01661121310.1016/j.ehj.2013.12.036Impact of fenestration creation on managing patients with protein loosing enteropathy complicating Fontan procedureMashail AlobaidanJasim AbdulhameedProtein loosing enteropathy (PLE) is well known complication following Fontan procedure and one way of managing such complication is to create fenestration if it is not present or enlarging it if it is small to reduce the Fontan pressure and reduce venous congestion which end up by intestinal protein loss. Aim: To evaluate the effect of such procedure in our population. Method: From February 2006 through October 2011 9 patients who underwent fenestration creation due to development of PLE was assessed in regard to clinical, laboratory result and hemodynamic effect prior and post procedure. Result: Median age is 7 years(4–21) , median weight is 23 kg (15–52) , male: female ratio is 3.5:1 ( male & 2 female), median saturation pre and post procedure was 93% and 82% respectively, median albumin pre and post procedure was 18 gm/dl and 31 gm/dl during the first 2 wks and 36 gm/dl thereafter, median pulmonary artery pressure before and after was 25 mmhg ( 17–32 mmhg) and 16 mmhg (14–19 mmhg), transpulmonary pressure gradient reduced from a median of 11 mmhg to 5 mmhg, No immediate deaths , 2 patients need re-dilatation, there was 2 (22%) late deaths (one t has stent thrombosis one month after followed by fulminant pulmonary embolism, though all patients were on anticoagulant other one with sudden arrest came to the emergency could not be resuscitated ) 3 (33%) patients have persistent low albumin though the fenestration is patent. Conclusion: Transcatheter fenestration creation as a management of PLE following Fontan procedure is feasible procedure, can be done in the cath. lab with little morbidity and mortality and with beneficial effect, however late complication and complete resolving of PLE is of concern especially if done late.http://www.sciencedirect.com/science/article/pii/S1110260813001555
collection DOAJ
language English
format Article
sources DOAJ
author Mashail Alobaidan
Jasim Abdulhameed
spellingShingle Mashail Alobaidan
Jasim Abdulhameed
Impact of fenestration creation on managing patients with protein loosing enteropathy complicating Fontan procedure
The Egyptian Heart Journal
author_facet Mashail Alobaidan
Jasim Abdulhameed
author_sort Mashail Alobaidan
title Impact of fenestration creation on managing patients with protein loosing enteropathy complicating Fontan procedure
title_short Impact of fenestration creation on managing patients with protein loosing enteropathy complicating Fontan procedure
title_full Impact of fenestration creation on managing patients with protein loosing enteropathy complicating Fontan procedure
title_fullStr Impact of fenestration creation on managing patients with protein loosing enteropathy complicating Fontan procedure
title_full_unstemmed Impact of fenestration creation on managing patients with protein loosing enteropathy complicating Fontan procedure
title_sort impact of fenestration creation on managing patients with protein loosing enteropathy complicating fontan procedure
publisher SpringerOpen
series The Egyptian Heart Journal
issn 1110-2608
publishDate 2014-03-01
description Protein loosing enteropathy (PLE) is well known complication following Fontan procedure and one way of managing such complication is to create fenestration if it is not present or enlarging it if it is small to reduce the Fontan pressure and reduce venous congestion which end up by intestinal protein loss. Aim: To evaluate the effect of such procedure in our population. Method: From February 2006 through October 2011 9 patients who underwent fenestration creation due to development of PLE was assessed in regard to clinical, laboratory result and hemodynamic effect prior and post procedure. Result: Median age is 7 years(4–21) , median weight is 23 kg (15–52) , male: female ratio is 3.5:1 ( male & 2 female), median saturation pre and post procedure was 93% and 82% respectively, median albumin pre and post procedure was 18 gm/dl and 31 gm/dl during the first 2 wks and 36 gm/dl thereafter, median pulmonary artery pressure before and after was 25 mmhg ( 17–32 mmhg) and 16 mmhg (14–19 mmhg), transpulmonary pressure gradient reduced from a median of 11 mmhg to 5 mmhg, No immediate deaths , 2 patients need re-dilatation, there was 2 (22%) late deaths (one t has stent thrombosis one month after followed by fulminant pulmonary embolism, though all patients were on anticoagulant other one with sudden arrest came to the emergency could not be resuscitated ) 3 (33%) patients have persistent low albumin though the fenestration is patent. Conclusion: Transcatheter fenestration creation as a management of PLE following Fontan procedure is feasible procedure, can be done in the cath. lab with little morbidity and mortality and with beneficial effect, however late complication and complete resolving of PLE is of concern especially if done late.
url http://www.sciencedirect.com/science/article/pii/S1110260813001555
work_keys_str_mv AT mashailalobaidan impactoffenestrationcreationonmanagingpatientswithproteinloosingenteropathycomplicatingfontanprocedure
AT jasimabdulhameed impactoffenestrationcreationonmanagingpatientswithproteinloosingenteropathycomplicatingfontanprocedure
_version_ 1724878093482459136